| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.19▼ | 11.19▼ | 11.19▼ | 10.91▼ | 11.39▼ |
| MA10 | 11.09▼ | 11.03▲ | 11.03▲ | 10.96▼ | 11.91▼ |
| MA20 | 10.92▲ | 10.91▲ | 10.95▲ | 11.53▼ | 12.37▼ |
| MA50 | 11.31▼ | 11.59▼ | 11.63▼ | 12.00▼ | N/A |
| MA100 | 11.93▼ | 12.03▼ | 12.05▼ | 12.50▼ | N/A |
| MA200 | 12.12▼ | 12.39▼ | 12.49▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.062▲ | 0.084▲ | 0.082▲ | -0.051▼ | N/A |
| RSI | 48.890▼ | 46.525▼ | 45.488▼ | 40.716▼ | 26.289▼ |
| STOCH | 74.583 | 75.229 | 75.265 | 24.837 | 27.142 |
| WILL %R | -48.750 | -48.148 | -48.148 | -85.039▼ | -89.130▼ |
| CCI | 9.145 | 25.912 | 25.954 | -49.735 | -153.922▼ |
| MA | $HBR Price Crossed Below MA(7) | Set Alert |
|
Thursday, April 30, 2026 11:06 AM
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/06/26 | 11.02 | 11.20 | 10.82 | 10.8423 | 41,596 |
| 16/06/26 | 11.24 | 11.30 | 10.99 | 11.03 | 31,143 |
| 15/06/26 | 11.32 | 11.48 | 11.235 | 11.26 | 118,563 |
| 12/06/26 | 10.74 | 10.855 | 10.555 | 10.62 | 50,481 |
| 11/06/26 | 10.66 | 10.826 | 10.50 | 10.815 | 143,283 |
| 10/06/26 | 10.73 | 10.90 | 10.60 | 10.61 | 392,873 |
| 09/06/26 | 10.97 | 11.00 | 10.72 | 10.9346 | 54,550 |
| 08/06/26 | 11.20 | 11.31 | 11.12 | 11.1391 | 65,847 |
| 05/06/26 | 11.23 | 11.2699 | 10.571 | 10.80 | 113,358 |
| 04/06/26 | 11.53 | 11.865 | 11.43 | 11.5362 | 51,202 |
|
|
||||
|
|
||||
|
|